Formulation strategies for nose-to-brain drug delivery in Alzheimer's disease-Reference-Cited by-同舟云学术

Formulation strategies for nose-to-brain drug delivery in Alzheimer's disease

Published:2023-03 Issue: Volume:6 Page:100075
ISSN:2772-6320
Container-title:Health Sciences Review
language:en
Short-container-title:Health Sciences Review

Author:

Vohra Manisha^ORCID,Amir Mohammad,Sharma Amit,Wadhwa Sheetu

Publisher

Elsevier BV

Reference68 articles.

1. Current understanding of Alzheimer's disease diagnosis and treatment;Weller;F1000Res,2018

2. Alzheimer's disease prevention: from risk factors to early intervention;Crous-Bou;Alzheimer's Res. Therapy,2017

3. Alzheimer's disease: risk factors and potentially protective measures;Silva;J. Biomed. Sci.,2019

4. Neuropathology of Alzheimer's disease;Trejo-Lopez;Neurotherapeutics,2021

5. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention;Kidd;Altern. Med. Rev.,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway;RSC Pharmaceutics;2024

2. Blood brain barrier and its significance in drug delivery to brain in Alzheimer disease;Alzheimer's Disease and Advanced Drug Delivery Strategies;2024

3. Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches;Neuroscience Letters;2023-11

4. Niosomes for nose-to-brain delivery: A non-invasive versatile carrier system for drug delivery in neurodegenerative diseases;Journal of Drug Delivery Science and Technology;2023-11

5. Drug Delivery Systems;Kirk-Othmer Encyclopedia of Chemical Technology;2023-09-29